Mergers and acquisitions are an integral part of the pharmaceutical industry that many companies rely on to bolster their portfolio of products, improve their R&D pipelines, and to improve their financial capabilities.
A new report published by the European Pharmaceutical Review stated that there more than 400 mergers and acquisitions have taken place in gene therapy, immuno-oncology, microbiome, and orphan drugs therapeutic categories since 2014.
Many of these acquisitions have involved high-profile companies. One of the most recognized M&As in the last five years was the acquisition of Shire by Takeda, an $80 billion deal that brought major changes to the industry.
One of the latest acquisitions was the $63 billion deal that saw AbbVie acquire Allergan. This merger is expected to significantly impact the pharma industry.
Other notable mergers in 2019 include:
Large M&As sometimes require companies in the pharmaceutical, biotech, and medical device industries to seek on-site training to ensure that their employees understand the impacts of these changes and how they may affect operations.
Are you looking to update your staff on the latest industry regulations and processes? Large M&As may require you to seek additional on-site training for your employees. CfPIE offers custom on-site training that you can use to get your new staff retrained quickly.
These courses offer significant benefits, including:
An M&A can mean that there are several new training modules for staff to get caught up on quickly. CfPIE’s on-site training can cover all of the important aspects you need to address. Sign up for our on-site training course today by calling 610-648-7550.
Stay Informed
Since 2001 CfPIE has
Need help finding the right life sciences training courses? We can help you make the right choice based on your company's needs.
All Rights Reserved | CfPIE Inc. | Our courses and materials are copyrighted by CfPIE, Inc. and may not be used or reproduced without the written permission of CfPIE, Inc. management. | In partnership with CCC